The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
Open accessAbstract
Virus infection of mammalian cells is sensed by pattern recognition receptors and leads to an innate immune response that restricts virus replication and induces adaptive immunity. In response, viruses have evolved many countermeasures that enable them to replicate and be transmitted to new hosts, despite the host innate immune response. Poxviruses, such as vaccinia virus (VACV), have large DNA genomes and encode many proteins that are dedicated to host immune evasion. Some of these proteins are secreted from the infected cell, where they bind and neutralize complement factors, interferons, cytokines and chemokines. Other VACV proteins function inside cells to inhibit apoptosis or signalling pathways that lead to the production of interferons and pro-inflammatory cytokines and chemokines. In this review, these VACV immunomodulatory proteins are described and the potential to create more immunogenic VACV strains by manipulation of the gene encoding these proteins is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 1×
“Various inflammasomes, which are activated by different molecular stimuli, can detect VACV infection and contribute to IL-1b production (Hornung et al., 2009; Gerlic et al., 2013), and VACV has evolved mechanisms to inhibit this process.”
BackgroundMitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
(1988) · World Health Organization eBooks · Cited by 1,574
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Elwood, J. M. (1989) · Journal of Epidemiology and Community Health · doi:10.1136/jech.43.1.92 · Cited by 1,412
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., & Pickup, D. J. (1992) · Cell · doi:10.1016/0092-8674(92)90223-y · Cited by 978
Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 977
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“TLR inhibitors are sought as targets for many inflammatory disorders (Kanzler et al., 2007) and compounds such as these T a b le 1 .”
BackgroundThe complete DNA sequence of vaccinia virus
Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P., & Paoletti, E. (1990) · Virology · doi:10.1016/0042-6822(90)90294-2 · Cited by 850
Heo, J., Reid, T., Ruo, L., Breitbach, C. J., Rose, S., Bloomston, M., Cho, M., Lim, H. Y., Chung, H. C., Kim, C. W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3089 · Cited by 779
Paludan, S. R., & Bowie, A. G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.004 · Cited by 759
Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730
Cutting edge: long-term B cell memory in humans after smallpox vaccination
Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695
The interferon response circuit: Induction and suppression by pathogenic viruses
Haller, O., Kochs, G., & Weber, F. (2006) · Virology · doi:10.1016/j.virol.2005.09.024 · Cited by 681
Silverman, R. H. (2007) · Journal of Virology · doi:10.1128/jvi.01471-07 · Cited by 671
Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A., & McFadden, G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141049 · Cited by 666
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Mackett, M., Smith, G. L., & Moss, B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7415 · Cited by 646
Self-citationTranslating Innate Immunity into Immunological Memory: Implications for Vaccine Development
Pulendran, B., & Ahmed, R. (2006) · Cell · doi:10.1016/j.cell.2006.02.019 · Cited by 625
Gracie, J. A., Robertson, S. E., & McInnes, I. B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602313 · Cited by 603
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter, G., & Moss, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10847 · Cited by 600
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency
Bogunovic, D., Byun, M., Durfee, L. A., Abhyankar, A., Sanal, O., Mansouri, D., Salem, S., Radovanovic, I., Grant, A. V., Adimi, P., et al. (2012) · Science · doi:10.1126/science.1224026 · Cited by 572
Jackson, R. J., Ramsay, A. J., Christensen, C. D., Beaton, S., Hall, D. F., & Ramshaw, I. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1205-1210.2001 · Cited by 565
The formation and function of extracellular enveloped vaccinia virus
Smith, G. L., Vanderplasschen, A., & Law, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-2915 · Cited by 559
Self-citationViral mimicry of cytokines, chemokines and their receptors
Alcami, A. (2003) · Nature Reviews Immunology · doi:10.1038/nri980 · Cited by 558
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Breitbach, C. J., Burke, J., Jonker, D., Stephenson, J., Haas, A. R., Chow, L. Q. M., Nieva, J., Hwang, T.-H., Moon, A., Patt, R., et al. (2011) · Nature · doi:10.1038/nature10358 · Cited by 551
Complications of Smallpox Vaccination, 1968: National Surveillance in the United States
Lane, J. M., Ruben, F. L., Neff, J. M., & Millar, J. D. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911272812201 · Cited by 545
Yewdell, J. W., Bennink, J. R., Smith, G. L., & Moss, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1785 · Cited by 521
Self-citationTarget Protease Specificity of the Viral Serpin CrmA
Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., & Salvesen, G. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7797 · Cited by 519
Antoine, G., Scheiflinger, F., Dorner, F., & Falkner, F. G. (1998) · Virology · doi:10.1006/viro.1998.9123 · Cited by 507
Panicali, D., & Paoletti, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.16.4927 · Cited by 497
Symons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490
Self-citationChang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
Alcami, A., & Smith, G. L. (1992) · Cell · doi:10.1016/0092-8674(92)90274-g · Cited by 482
Self-citationSpecific and nonspecific NK cell activation during virus infection
Dokun, A. O., Kim, S., Smith, H. R. C., Kang, H.-S. P., Chu, D. T., & Yokoyama, W. M. (2001) · Nature Immunology · doi:10.1038/ni714 · Cited by 477
Meyer, H., Sutter, G., & Mayr, A. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-5-1031 · Cited by 474
Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S., & Krug, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504754102 · Cited by 472
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
Self-citationInfectious vaccinia virus recombinants that express hepatitis B virus surface antigen
Smith, G. L., Mackett, M., & Moss, B. (1983) · Nature · doi:10.1038/302490a0 · Cited by 420
Self-citationVirus interference. II. Some properties of interferon
Isaacs, A., Lindenmann, J., & Valentine, R. C. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0049 · Cited by 413
Poxvirus genomes: a phylogenetic analysis
Gubser, C., Hué, S., Kellam, P., & Smith, G. L. (2004) · Journal of General Virology · doi:10.1099/vir.0.19565-0 · Cited by 406
Self-citationDNA-PK is a DNA sensor for IRF-3-dependent innate immunity
Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H., & Smith, G. L. (2012) · eLife · doi:10.7554/elife.00047 · Cited by 404
Self-citationTargeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
Kirn, D. H., & Thorne, S. H. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2545 · Cited by 402
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K., & Welsh, R. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.3.1531 · Cited by 394
Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., & Buller, R. M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15974 · Cited by 386
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process
Dinarello, C. A. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.447s · Cited by 384
Pulendran, B., Li, S., & Nakaya, H. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.006 · Cited by 380
Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation
Schröder, M., Baran, M., & Bowie, A. G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.143 · Cited by 375
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
Self-citationStack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., & Bowie, A. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041442 · Cited by 369
Self-citationAntiviral defense in mice lacking both alpha/beta and gamma interferon receptors
van den Broek, M. F., Müller, U., Huang, S., Aguet, M., & Zinkernagel, R. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4792-4796.1995 · Cited by 363
Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
Kotwal, G. J., & Moss, B. (1988) · Nature · doi:10.1038/335176a0 · Cited by 346
Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules
Wang, Z., Choi, M. K., Ban, T., Yanai, H., Negishi, H., Lu, Y., Tamura, T., Takaoka, A., Nishikura, K., & Taniguchi, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801295105 · Cited by 336
Blanchard, T. J., Andrea, P., Alcami, A., & Smith, G. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-5-1159 · Cited by 336
Self-citationComplications of Smallpox Vaccination: National Survey in the United States, 1963
Neff, J. M., Lane, J. M., Pert, J. H., Moore, R., Millar, J. D., & Henderson, D. A. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760301 · Cited by 329
Soulat, D., Bürckstümmer, T., Westermayer, S., Goncalves, A., Bauch, A., Stefanovic, A., Hantschel, O., Bennett, K. L., Decker, T., & Superti-Furga, G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.126 · Cited by 325
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA
Smith, G. L., & Moss, B. (1983) · Gene · doi:10.1016/0378-1119(83)90163-4 · Cited by 324
Self-citationVaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
Spriggs, M. K., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. L., & VanSlyke, J. (1992) · Cell · doi:10.1016/0092-8674(92)90273-f · Cited by 319
Encoding of a Homolog of the IFN-γ Receptor by Myxoma Virus
Upton, C., Mossman, K., & McFadden, G. (1992) · Science · doi:10.1126/science.1455233 · Cited by 304
Alcamí, A., & Smith, G. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4633-4639.1995 · Cited by 301
Self-citationSmith, G. L., Murphy, B. R., & Moss, B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7155 · Cited by 295
Self-citationVaccinia virus vaccines: Past, present and future
Jacobs, B. L., Langland, J. O., Kibler, K. V., Denzler, K. L., White, S. D., Holechek, S. A., Wong, S., Huynh, T., & Baskin, C. R. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.06.006 · Cited by 279
Vaccinia virus morphogenesis and dissemination
Roberts, K. L., & Smith, G. L. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.07.009 · Cited by 278
Self-citationPaoletti, E., Lipinskas, B. R., Samsonoff, C., Mercer, S., & Panicali, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.1.193 · Cited by 275
Alcamı́, A., Symons, J. A., & Smith, G. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11230-11239.2000 · Cited by 273
Self-citationCellular and Humoral Immunity against Vaccinia Virus Infection of Mice
Xu, R., Johnson, A. J., Liggitt, D., & Bevan, M. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6265 · Cited by 260
Smallpox vaccines: targets of protective immunity
Moss, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00975.x · Cited by 259
Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus
Alcamí, A., Symons, J. A., Collins, P. D., Williams, T. J., & Smith, G. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.624 · Cited by 252
Self-citationVanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R. B., & Smith, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7544 · Cited by 249
Self-citationWyatt, L. S., Earl, P. L., Eller, L. A., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401165101 · Cited by 247
Isaacs, S. N., Kotwal, G. J., & Moss, B. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.628 · Cited by 243
Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A., & Alcami, A. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01012.x · Cited by 239
Self-citationKim, M.-J., Hwang, S.-Y., Imaizumi, T., & Yoo, J.-Y. (2008) · Journal of Virology · doi:10.1128/jvi.01650-07 · Cited by 238
Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon
Beattie, E., Tartaglia, J., & Paoletti, E. (1991) · Virology · doi:10.1016/0042-6822(91)90158-8 · Cited by 234
Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M. A., Huang, D. C. S., & Colman, P. M. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.83 · Cited by 233
DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A., & Marshall, W. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400567200 · Cited by 233
Panicali, D., Davis, S. W., Weinberg, R. L., & Paoletti, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5364 · Cited by 227
A role for Z-DNA binding in vaccinia virus pathogenesis
Kim, Y.-G., Muralinath, M., Brandt, T., Pearcy, M., Hauns, K., Lowenhaupt, K., Jacobs, B. L., & Rich, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0431131100 · Cited by 223
Brandt, T. A., & Jacobs, B. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.850-856.2001 · Cited by 217
Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L.-Y., Lucas, A., Clark-Lewis, I., Moyer, R. W., & Mcfadden, G. (1997) · Virology · doi:10.1006/viro.1996.8423 · Cited by 215
Engelstad, M., Howard, S. T., & Smith, G. L. (1992) · Virology · doi:10.1016/0042-6822(92)90535-w · Cited by 214
Self-citationPrevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression
Flexner, C., Hügin, A., & Moss, B. (1987) · Nature · doi:10.1038/330259a0 · Cited by 213
Kettle, S., Khanna, A., Alcam√≠, A., Jassoy, C., Ehret, R., & Smith, G. L. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-3-677 · Cited by 206
Self-citationTargeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
Kirn, D. H., Wang, Y., Le Boeuf, F., Bell, J., & Thorne, S. H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040353 · Cited by 203
Hu, F.-Q., Smith, C. A., & Pickup, D. J. (1994) · Virology · doi:10.1006/viro.1994.1539 · Cited by 193
Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells
Kibler, K. V., Shors, T., Perkins, K. B., Zeman, C. C., Banaszak, M. P., Biesterfeldt, J., Langland, J. O., & Jacobs, B. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1992-2003.1997 · Cited by 192
Smith, C. A., Smith, T. D., Smolak, P. J., Friend, D., Hagen, H., Gerhart, M., Park, L., Pickup, D. J., Torrance, D., Mohler, K., et al. (1997) · Virology · doi:10.1006/viro.1997.8730 · Cited by 189
Najarro, P., Traktman, P., & Lewis, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3185-3196.2001 · Cited by 188
Carroll, K., Elroy-Stein, O., Moss, B., & Jagus, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31463-7 · Cited by 184
A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response
Born, T. L., Morrison, L. A., Esteban, D. J., VandenBos, T., Thebeau, L. G., Chen, N., Spriggs, M. K., Sims, J. E., & Buller, R. M. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3246 · Cited by 182
The Vaccinia Virus K1L Gene Product Inhibits Host NF-κB Activation by Preventing IκBα Degradation
Shisler, J. L., & Jin, X.-L. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3553-3560.2004 · Cited by 177
Cooray, S., Bahar, M. W., Abrescia, N. G. A., McVey, C. E., Bartlett, N. W., Chen, R. A.-J., Stuart, D. I., Grimes, J. M., & Smith, G. L. (2007) · Journal of General Virology · doi:10.1099/vir.0.82772-0 · Cited by 172
Self-citationUnterholzner, L., Sumner, R. P., Baran, M., Ren, H., Mansur, D. S., Bourke, N. M., Randow, F., Smith, G. L., & Bowie, A. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002247 · Cited by 170
Self-citationInterleukin-18 Protects Mice against Acute Herpes Simplex Virus Type 1 Infection
Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M., & Kurimoto, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2401-2409.1999 · Cited by 169
Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis
Wasilenko, S. T., Stewart, T. L., Meyers, A. F. A., & Barry, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235583100 · Cited by 169
Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A.-J., Whalen, D. M., Abrescia, N. G. A., Alderton, D., Owens, R. J., Stuart, D. I., Smith, G. L., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000128 · Cited by 168
Self-citationProtection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product
Dobbelstein, M., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6479-6485.1996 · Cited by 165
Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15
Guerra, S., Cáceres, A., Knobeloch, K., Horak, I. D., & Estéban, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000096 · Cited by 164
Regulation of Complement Activity by Vaccinia Virus Complement-Control Protein
McKenzie, R., Kotwal, G. J., Moss, B., Hammer, C. H., & Frank, M. M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1245 · Cited by 164
Gubser, C., & Smith, G. L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-4-855 · Cited by 161
Self-citationSmith, G. L., Chan, Y. S., & Howard, S. T. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-6-1349 · Cited by 159
Self-citationInhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14
Chen, R. A.-J., Ryzhakov, G., Cooray, S., Randow, F., & Smith, G. L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040022 · Cited by 155
Self-citationA Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
Fang, M., Lanier, L. L., & Sigal, L. J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040030 · Cited by 155
Species Specificity of Ectromelia Virus and Vaccinia Virus Interferon-γ Binding Proteins
Mossman, K. L., Upton, C., Buller, R. M. L., & McFadden, G. (1995) · Virology · doi:10.1006/viro.1995.1208 · Cited by 152
Lysakova-Devine, T., Keogh, B., Harrington, B., Nagpal, K., Halle, A., Golenbock, D. T., Monie, T. P., & Bowie, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002013 · Cited by 150
Pütz, M. M., Midgley, C. M., Law, M., & Smith, G. L. (2006) · Nature Medicine · doi:10.1038/nm1457 · Cited by 150
Self-citationA mechanism for the inhibition of fever by a virus.
Alcamı́, A., & Smith, G. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11029 · Cited by 149
Self-citationA chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus
Alejo, A., Ruiz-Argüello, M. B., Ho, Y. Y., Smith, V. P., Saraiva, M., & Alcamí, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510462103 · Cited by 148
Benhnia, M. R., McCausland, M. M., Moyron‐Quiroz, J., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Kubo, R. T., Kato, S., & Crotty, S. (2008) · Journal of Virology · doi:10.1128/jvi.01797-08 · Cited by 143
Sharma, D. P., Ramsay, A. J., Maguire, D. J., Rolph, M. S., & Ramshaw, I. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7103-7107.1996 · Cited by 141
Immunology 101 at poxvirus U: Immune evasion genes
Moss, B. A., & Shisler, J. L. (2001) · Seminars in Immunology · doi:10.1006/smim.2000.0296 · Cited by 139
Gómez, C. E., Nájera, J. L., Krupa, M., & Estéban, M. (2008) · Current Gene Therapy · doi:10.2174/156652308784049363 · Cited by 139
Gillard, G. O., Bivas‐Benita, M., Hovav, A., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002141 · Cited by 136
Sequential Protein Synthesis Following Vaccinia Virus Infection
Moss, B., & Salzman, N. P. (1968) · Journal of Virology · doi:10.1128/jvi.2.10.1016-1027.1968 · Cited by 135
Delano, M. L., & Brownstein, D. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5875-5877.1995 · Cited by 133
ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.
Lu, G., Reinert, J. T., Pitha, I., Okumura, A., Kellum, M. J., Knobeloch, K., Hassel, B., & Pitha, P. M. (2006) · PubMed · Cited by 129
Tscharke, D. C., Reading, P. C., & Smith, G. L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1977 · Cited by 128
Self-citationMartinez, J., Huang, X., & Yang, Y. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000811 · Cited by 124
Alcam√≠, A., Khanna, A., Paul, N. L. M., & Smith, G. L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-949 · Cited by 123
Self-citationA New Inhibitor of Apoptosis from Vaccinia Virus and Eukaryotes
Keller, C. G., Bergamaschi, D., Hollinshead, M. S., Lü, X., van Kuppeveld, F. J. M., & Smith, G. L. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030017 · Cited by 122
Self-citationModulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hämmerling, G. J., Gati, C., Cerwenka, A., Turner, P., Moyer, R. W., Watzl, C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002195 · Cited by 121
CD94 Is Essential for NK Cell-Mediated Resistance to a Lethal Viral Disease
Fang, M., Orr, M. T., Spee, P., Egebjerg, T., Lanier, L. L., & Sigal, L. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.015 · Cited by 121
Smith, G. L., & Chan, Y. S. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-511 · Cited by 119
Self-citationVaccinia virus N1L protein resembles a B cell lymphoma‐2 (Bcl‐2) family protein
Aoyagi, M., Zhai, D., Jin, C., Aleshin, A. E., Stec, B., Reed, J. C., & Liddington, R. (2006) · Protein Science · doi:10.1110/ps.062454707 · Cited by 117
A Mechanism for the Inhibition of DNA-PK-Mediated DNA Sensing by a Virus
Peters, N., Ferguson, B. J., Mazzon, M., Fahy, A. S., Krysztofinska, E., Arribas-Bosacoma, R., Pearl, L. H., Ren, H., & Smith, G. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003649 · Cited by 117
Self-citationBartlett, N., Buttigieg, K., Kotenko, S., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80904-0 · Cited by 117
Self-citationImmunodeficient mice recover from infection with vaccinia virus expressing interferon‐γ
Kohonen‐Corish, M. R. J., King, N. J. C., Woodhams, C. E., & Ramshaw, I. A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200123 · Cited by 115
Systems vaccinology: learning to compute the behavior of vaccine induced immunity
Nakaya, H. I., Li, S., & Pulendran, B. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.163 · Cited by 114
Reading, P. C., & Smith, G. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9960-9968.2003 · Cited by 114
Self-citationKettle, S., BLAKE, N. W., Law, K. M., & Smith, G. L. (1995) · Virology · doi:10.1016/s0042-6822(95)80028-x · Cited by 112
Self-citationPáez, E. O., & Estéban, M. (1984) · Virology · doi:10.1016/0042-6822(84)90268-x · Cited by 112
Ennis, F. A., Cruz, J., Demkowicz, W. E., Rothman, A. L., & McClain, D. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/340517 · Cited by 112
Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation
Gerlic, M., Faustin, B., Postigo, A. A., Yu, E. C.-W., Proell, M., Gombosuren, N., Krajewska, M., Flynn, R., Croft, M., Way, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215995110 · Cited by 110
Natuk, R. J., & Welsh, R. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.877 · Cited by 109
Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus
Carfí, A., Smith, C. A., Smolak, P. J., McGrew, J. T., & Wiley, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12379 · Cited by 109
Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy
Lee, D., & Hung, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0123 · Cited by 108
Mann, B. A., Huang, J. H., Li, P., Chang, H., Slee, R. B., O’Sullivan, A., Anita, M., Yeh, N., Klemsz, M. J., Brutkiewicz, R. R., et al. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0113 · Cited by 101
Wasilenko, S. T., Banadyga, L., Bond, D., & Barry, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14031-14043.2005 · Cited by 100
Chisholm, S., & Reyburn, H. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2225-2233.2006 · Cited by 100
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
Walsh, S. R., & Dolin, R. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.79 · Cited by 99
Gedey, R., Jin, X.-L., Hinthong, O., & Shisler, J. L. (2006) · Journal of Virology · doi:10.1128/jvi.00935-06 · Cited by 98
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.
Moore, J. B., & Smith, G. L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05251.x · Cited by 96
Self-citationde Motes, C. M., Cooray, S., Ren, H., Almeida, G. M. D. F., McGourty, K., Bahar, M. W., Stuart, D. I., Grimes, J. M., Graham, S. C., & Smith, G. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002430 · Cited by 95
Self-citationMyskiw, C., Arsenio, J., van Bruggen, R., Deschambault, Y., & Cao, J. (2009) · Journal of Virology · doi:10.1128/jvi.02570-08 · Cited by 93
Waibler, Z., Anzaghe, M., Frenz, T., Schwantes, A., Pöhlmann, C., Ludwig, H., Palomo-Otero, M., Alcamí, A., Sutter, G., & Kalinke, U. (2008) · Journal of Virology · doi:10.1128/jvi.01617-08 · Cited by 92
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
Clark, R. H., Kenyon, J. C., Bartlett, N. W., Tscharke, D. C., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.81417-0 · Cited by 91
Self-citationGarcía‐Arriaza, J., Nájera, J. L., Gómez, C. E., Tewabe, N., Sorzano, C. Ó. S., Calandra, T., Roger, T., & Estéban, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024244 · Cited by 90
Kalverda, A. P., Thompson, G. S., Vogel, A., Schröder, M., Bowie, A., Khan, A. R., & Homans, S. W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.048 · Cited by 89
A mechanism for induction of a hypoxic response by vaccinia virus
Mazzon, M., Peters, N., Loenarz, C., Krysztofinska, E., Ember, S. W., Ferguson, B. J., & Smith, G. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302140110 · Cited by 87
Self-citationVaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
Ferguson, B. J., Benfield, C. T. O., Ren, H., Lee, V. H., Frazer, G. L., Strnadova, P., Sumner, R. P., & Smith, G. L. (2013) · Journal of General Virology · doi:10.1099/vir.0.054114-0 · Cited by 86
Self-citationVerardi, P. H., Jones, L. A., Aziz, F. H., Ahmad, S., & Yilma, T. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.11-18.2001 · Cited by 86
Induction of Human T Cell–Mediated Immune Responses after Primary and Secondary Smallpox Vaccination
Kennedy, J. S., Frey, S. E., Yan, L. K., Rothman, A. L., Cruz, J., Newman, F. K., Orphin, L., Belshe, R. B., & Ennis, F. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/423848 · Cited by 84
Guerra, S., López-Fernández, L. A., Conde-Álvarez, R., Pascual-Montano, A., Harshman, K., & Estéban, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5820-5834.2004 · Cited by 84
Postigo, A. A., Cross, J. R., Downward, J., & Way, M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401853 · Cited by 83
Structural Basis for Targeting of Human RNA Helicase DDX3 by Poxvirus Protein K7
Oda, S.-I., Schröder, M., & Khan, A. R. (2009) · Structure · doi:10.1016/j.str.2009.09.005 · Cited by 82
García‐Arriaza, J., Nájera, J. L., Gómez, C. E., Sorzano, C. Ó. S., & Estéban, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012395 · Cited by 81
Steroid Hormone Synthesis by Vaccinia Virus Suppresses the Inflammatory Response to Infection
Reading, P. C., Moore, J. B., & Smith, G. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022201 · Cited by 81
Self-citationSymons, J. A., Adams, E., Tscharke, D. C., Reading, P. C., Waldmann, H., & Smith, G. L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-11-2833 · Cited by 79
Self-citationOrthopoxvirus IL-18 Binding Proteins: Affinities and Antagonist Activities
Calderara, S., Xiang, Y., & Moss, B. (2001) · Virology · doi:10.1006/viro.2000.0689 · Cited by 78
Uncovering the Interplay Between CD8, CD4 and Antibody Responses to Complex Pathogens
Moutaftsi, M., Tscharke, D. C., Vaughan, K. C., Koelle, D. M., Stern, L. J., Calvo-Calle, M., Ennis, F. A., Terajima, M., Sutter, G., Crotty, S., et al. (2010) · Future Microbiology · doi:10.2217/fmb.09.110 · Cited by 78
Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I Interferons
Meng, X., Jiang, C., Arsenio, J., Dick, K., Cao, J., & Xiang, Y. (2009) · Journal of Virology · doi:10.1128/jvi.01260-09 · Cited by 77
Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein
Bahar, M. W., Kenyon, J. C., Pütz, M. M., Abrescia, N. G. A., Pease, J. E., Wise, E. L., Stuart, D. I., Smith, G. L., & Grimes, J. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040005 · Cited by 77
Self-citationPathogen-derived immunomodulatory molecules: future immunotherapeutics?
Fallon, P. G., & Alcamí, A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.08.002 · Cited by 72
Tardif, J., L’Allier, P. L., Grégoire, J. C., Ibrahim, R., McFadden, G., Kostuk, W. J., Knudtson, M. L., Labinaz, M. X., Waksman, R., Pepine, C. J., et al. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.953885 · Cited by 72
Saraiva, N., Prole, D. L., Carrara, G., Johnson, B. F., Taylor, C. W., Parsons, M., & Smith, G. L. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201301016 · Cited by 70
Self-citationPrevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy
Pütz, M. M., Alberini, I., Midgley, C. M., Manini, I., Montomoli, E., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.81265-0 · Cited by 69
Self-citationComprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein
Burns, J. M., Dairaghi, D. J., Deitz, M., Tsang, M., & Schall, T. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109884200 · Cited by 69
Poxviruses: Interfering with Interferon
Smith, G. L., Symons, J. A., & Alcamí, A. (1998) · Seminars in Virology · doi:10.1006/smvy.1997.0145 · Cited by 68
Self-citationValentine, R., & Smith, G. L. (2010) · Journal of General Virology · doi:10.1099/vir.0.021998-0 · Cited by 68
Self-citationHuman Golgi Antiapoptotic Protein Modulates Intracellular Calcium Fluxes
de Mattia, F., Keller, C. G., van Dommelen, M. M. T., Visch, H.-J., Distelmaier, F., Postigo, A. A., Luyten, T., Parys, J. B., SMEDT, H. D., Smith, G. L., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0385 · Cited by 65
Self-citationVaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor
Chen, R. A.-J., Jacobs, N., & Smith, G. L. (2006) · Journal of General Virology · doi:10.1099/vir.0.81736-0 · Cited by 65
Self-citationZhang, L., DeRider, M. L., McCornack, M. A., Jao, S., Isern, N., Ness, T. L., Moyer, R. W., & LiWang, P. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602142103 · Cited by 60
Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein
Falivene, J., Zajac, M. P. D. M., Pascutti, M. F., Rodríguez, A. M., Maeto, C., Perdiguero, B., Gómez, C. E., Estéban, M., Calamante, G., & Gherardi, M. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032220 · Cited by 59
Reading, P. C., Symons, J. A., & Smith, G. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1435 · Cited by 58
Self-citationMcCoy, S. L., Kurtz, S. E., MacArthur, C. J., Trune, D. R., & Hefeneider, S. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3006 · Cited by 58
Rice, A. D., Turner, P., Embury, J. E., Moldawer, L. L., Baker, H. V., & Moyer, R. W. (2010) · Journal of Virology · doi:10.1128/jvi.00254-10 · Cited by 58
Montanuy, I., Alejo, A., & Alcamı́, A. (2011) · The FASEB Journal · doi:10.1096/fj.10-177188 · Cited by 57
Ruiz-Argüello, M. B., Smith, V. P., Campanella, G. S. V., Baleux, F., Arenzana‐Seisdedos, F., Luster, A. D., & Alcamí, A. (2007) · Journal of Virology · doi:10.1128/jvi.02111-07 · Cited by 57
Alcamı́, A., & Smith, G. L. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10051-2 · Cited by 56
Self-citationHammaker, D. R., Boyle, D. L., & Firestein, G. S. (2011) · Rheumatology · doi:10.1093/rheumatology/ker154 · Cited by 55
Immunotherapeutic potential of oncolytic vaccinia virus
Thorne, S. H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8211-4 · Cited by 55
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L
García, M. Á., Guerra, S., Gil, J., Jiménez, V., & Estéban, M. (2002) · Oncogene · doi:10.1038/sj.onc.1206036 · Cited by 54
Benfield, C. T. O., Mansur, D. S., McCoy, L. E., Ferguson, B. J., Bahar, M. W., Oldring, A. P., Grimes, J. M., Stuart, D. I., Graham, S. C., & Smith, G. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231381 · Cited by 53
Self-citationWang, L. S., Lynn, R. C., Cheng, G., Alexander, E., Kapoor, V., Moon, E. K., Sun, J., Fridlender, Z. G., Isaacs, S. N., Thorne, S. H., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.228 · Cited by 49
Brum, L. M., López, M. C., Varela, J. C., Baker, H. V., & Moyer, R. W. (2003) · Virology · doi:10.1016/s0042-6822(03)00532-4 · Cited by 48
Xue, X., Lu, Q., Wei, H., Wang, D., Chen, D., He, G., Huang, L., Wang, H., & Wang, X. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002162 · Cited by 46
Structure of CrmE, a Virus-encoded Tumour Necrosis Factor Receptor
Graham, S. C., Bahar, M. W., Abrescia, N. G. A., Smith, G. L., Stuart, D. I., & Grimes, J. M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.082 · Cited by 44
Self-citationWyatt, L. S., Earl, P. L., Vogt, J., Eller, L. A., Chandran, D., Liu, J., Robinson, H. L., & Moss, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.036 · Cited by 43
Cited by
Monkeypox: disease epidemiology, host immunity and clinical interventions
Lum, F.-M., Torres-Ruesta, A., Tay, M. Z., Lin, R. T. P., Lye, D. C., Rénia, L., & Ng, L. F. P. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00775-4 · Cited by 541
Die another way – non-apoptotic mechanisms of cell death
Tait, S. W. G., Ichim, G., & Green, D. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.093575 · Cited by 366
IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes
Almine, J. F., O’Hare, C. A. J., Dunphy, G., Haga, I. R., Naik, R. J., Atrih, A., Connolly, D. J., Taylor, J., Kelsall, I. R., Bowie, A. G., et al. (2017) · Nature Communications · doi:10.1038/ncomms14392 · Cited by 340
Modified Vaccinia Virus Ankara
Volz, A., & Sutter, G. (2017) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.07.001 · Cited by 323
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Guo, Z. S., Lu, B., Guo, Z., Giehl, E., Feist, M., Dai, E., Liu, W., Storkus, W. J., He, Y., Liu, Z., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0495-7 · Cited by 292
Metadata
- Authors
- Smith, G. L., Benfield, C. T. O., Maluquer de Motes, C., Mazzon, M., Ember, S. W. J., Ferguson, B. J., & Sumner, R. P.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2013-11-01
- Volume
- 94
- Issue
- 11
- Pages
- 2367-2392
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W1989893709
- Cited by
- 364
- References
- 212
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.